Medlab: Chronic Disease Research and Innovation
Medlab Efficacy Magazine

Medlab's New EfficacyTM Magazine

A true integrative approach to medicine and health

Issue 4: June 2017 - August 2017

Neuro-Cognitive Impairments


Medlab’s quarterly magazine designed to educate and update Practitioners with Medlab research and industry advancements with a variety of contributing authors. Register or log in to view today.

Featured News

NutraIngredient Awards 2017 Finalist

We are proud to announce Medlab's NRGBiotic™ is a finalist for the NutraIngredient Awards 2017 - Readers' Food Supplement of the Year!
NRGBioticTM is a valuable addition to many Practitioners 'toolbox' and is equally loved by those that use the product. The current clinical research outcomes have provided a novel adjunct option for those with Depression.
Seek advice from your healthcare Practitioner. Find out more about NRGBiotic:


NRGBiotic

FEATURED PRODUCTS
Mg Optima™ Relax Featured product

12Mg Optima Relax

Please seek advice from your healthcare practitioner to see if this product is suitable for you.

Always read the label, use only as directed.

Find out more here

FEATURED CONFERENCE

Lifestyle Medicine 2017

We are proud to announce Professor Luis Vitetta will be presenting at the conference, ‘Mood disorders and the Intestinal Mucosa’, and Medlab will be exhibiting, we hope to see you there!

ACNEM 2017

Check out the full list of streams, workshops and register now here. For a limited time, you can use the conference promo code PASSIONATE for an extra passionate supporter discount.

NEWS

New NanoCelleTM NanoStatTM could help tackle high cholesterol

Featured on Channel Nine News on the 9th of March 2017



Congratulations to the Medlab team! Best early-phase chronic disease drug discovery company. Click the link to review the article, featured on pages 16 and 17.


Best Early-Phase Chronic Disease Drug Discovery Company Award



Medlab's research featured on Channel 9 news

Medlab Clinical is at the forefront of research into obesity and the prevention of diabetes. Medlab's probiotic formulation is currently undergoing clinical trial evaluation in collaboration with the University of Sydney's Boden Institute as featured in a recent Channel 9 news item.

Watch Interview